Sentence examples for diversity of trials from inspiring English sources

The diversity of trials and interventions identified in the review were not anticipated.

The diversity of trials and interventions identified meant that not all of our prespecified subgroup analyses were appropriate or possible.

The proliferation and diversity of trials, with varying interpretations of the standard of care, has led to endless conjecture on the best treatment, and much discussion of the route by which the 'latest' regimen to be tested has evolved.

These figures are intended to helpfully summarise the data only; we emphasise that the mixed quality and diversity of trials in this review prevented explanatory meta-analyses from being undertaken, since the results would risk being misleading or erroneous, and we do not intend these figures to be interpreted in this way.

The schemes increase the diversity of trial vectors and improve on the exploration capabilities of Differential Evolution.

Nevertheless, despite the diversity of trial designs used in these early studies, they supported the case for early response assessment and showed that larger scale prospective trials with well-defined cohorts of patients with similar types of lymphoma and therapies would be worthwhile.

However, we identified such a diversity of retention trials and interventions that these analyses were inappropriate or not possible.

To capture the diversity of the Indian trial sites, the participant interviews took place across a selection of six of these sites and were conducted in English or appropriate local languages.

More insight into the benefits of such courses will be gained by investigating a wider diversity of cohorts and trialling longer courses of study so that participants have a longer period of time to consider whether to register for organ donation.

The diversity rank-score function can be used as a guiding light to combine pairs of visual perception systems based on the diversity variation across a set of trials.

Similarly, improving the diversity of participants in clinical trials to reflect the intended patient population, may help regulators and clinicians better assess the real world performance of these therapeutics.